Ophthalmology · Vacaville, CA
NPI
1023080355
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
3700 Vaca Valley Pkwy, Kaiser Permanente Ophthalmology Department
Vacaville, CA, 95688
Phone (707) 453-5600
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$76K
2,303 prescriptions
Company payments, 2025
$106
From 1 companies
Medicare prescription drug claims, 2024
In 2024, the drug Charles Q Huang prescribed most often to Medicare patients was Latanoprost, with 744 prescriptions and refills. In total Charles Q Huang wrote 2,303 Medicare prescriptions that cost $76K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-02-11.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Latanoprost Generic | 744 | 2,379 | 312 | $12K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 462 | 1,494 | 161 | $12K |
| Diclofenac Sodium Generic | 227 | 230 | 177 | $3,867 |
| Brimonidine Tartrate Generic | 220 | 717 | 93 | $3,875 |
| Timolol Maleate Generic | 169 | 556 | 72 | $3,764 |
| Levobunolol Hcl Generic | 134 | 437 | 48 | $5,090 |
| Prednisolone Acetate Generic | 90 | 101 | 65 | $3,461 |
| Cyclosporine Generic | 59 | 65 | 19 | $5,918 |
| Dorzolamide Hcl Generic | 29 | 88 | 12 | $727 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 29 | 29 | 20 | $374 |
| Erythromycin Erythromycin Base | 22 | 22 | 16 | $296 |
| Fluorometholone Generic | 21 | 37 | Under 11 | $2,663 |
| Polymyxin B Sul-Trimethoprim Polymyxin B Sulf/Trimethoprim | 20 | 20 | 18 | $238 |
| Bimatoprost Generic | 15 | 34 | Under 11 | $1,261 |
Brand drugs: 185 claims; generic drugs: 2,118 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Charles Q Huang $106 ($106 in general payments such as food, travel and fees) from 1 company. The largest payer was Tarsus Pharmaceuticals, Inc. with $106.
| Company | Payments | Amount |
|---|---|---|
| Tarsus Pharmaceuticals, Inc. TARS | 1 | $106 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.